Literature DB >> 10787420

Crystal structure of the allergen Equ c 1. A dimeric lipocalin with restricted IgE-reactive epitopes.

M B Lascombe1, C Grégoire, P Poncet, G A Tavares, I Rosinski-Chupin, J Rabillon, H Goubran-Botros, J C Mazié, B David, P M Alzari.   

Abstract

The three-dimensional structure of the major horse allergen Equ c 1 has been determined at 2.3 A resolution by x-ray crystallography. Equ c 1 displays the typical fold of lipocalins, a beta-barrel flanked by a C-terminal alpha-helix. The space between the two beta-sheets of the barrel defines an internal cavity that could serve, as in other lipocalins, for the binding and transport of small hydrophobic ligands. Equ c 1 crystallizes in a novel dimeric form, which is distinct from that observed in other lipocalin dimers and corresponds to the functional form of the allergen. Binding studies of point mutants of the allergen with specific monoclonal antibodies raised in mouse and IgE serum from horse allergic patients allowed to identify putative B cell antigenic determinants. In addition, total inhibition of IgE serum recognition by a single specific monoclonal antibody revealed the restricted nature of the IgE binding target on the molecular surface of Equ c 1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10787420     DOI: 10.1074/jbc.M002854200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Recombinant allergens.

Authors:  C Grégoire; M D Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2001-10       Impact factor: 8.667

2.  Der p 5 crystal structure provides insight into the group 5 dust mite allergens.

Authors:  Geoffrey A Mueller; Rajendrakumar A Gosavi; Joseph M Krahn; Lori L Edwards; Matthew J Cuneo; Jill Glesner; Anna Pomés; Martin D Chapman; Robert E London; Lars C Pedersen
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

3.  Mutation analysis of violaxanthin de-epoxidase identifies substrate-binding sites and residues involved in catalysis.

Authors:  Giorgia Saga; Alejandro Giorgetti; Christian Fufezan; Giorgio M Giacometti; Roberto Bassi; Tomas Morosinotto
Journal:  J Biol Chem       Date:  2010-05-27       Impact factor: 5.157

4.  Crystal structure of a dimerized cockroach allergen Bla g 2 complexed with a monoclonal antibody.

Authors:  Mi Li; Alla Gustchina; Jerry Alexandratos; Alexander Wlodawer; Sabina Wünschmann; Christopher L Kepley; Martin D Chapman; Anna Pomés
Journal:  J Biol Chem       Date:  2008-06-02       Impact factor: 5.157

Review 5.  Relevant B cell epitopes in allergic disease.

Authors:  Anna Pomés
Journal:  Int Arch Allergy Immunol       Date:  2009-11-26       Impact factor: 2.749

6.  Animal lipocalin allergens.

Authors:  Christiane Hilger; Annette Kuehn; Francois Hentges
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

7.  Generation mechanism of novel, huge protein bodies containing wild type or hypoallergenic derivatives of birch pollen allergen Bet v 1 in rice endosperm.

Authors:  Yuko Ogo; Hideyuki Takahashi; Shuyi Wang; Fumio Takaiwa
Journal:  Plant Mol Biol       Date:  2014-07-08       Impact factor: 4.076

8.  Homology modeling and characterization of IgE binding epitopes of mountain cedar allergen Jun a 3.

Authors:  K V Soman; T Midoro-Horiuti; J C Ferreon; R M Goldblum; E G Brooks; A Kurosky; W Braun; C H Schein
Journal:  Biophys J       Date:  2000-09       Impact factor: 4.033

9.  Role of conserved residues in structure and stability: tryptophans of human serum retinol-binding protein, a model for the lipocalin superfamily.

Authors:  L H Greene; E D Chrysina; L I Irons; A C Papageorgiou; K R Acharya; K Brew
Journal:  Protein Sci       Date:  2001-11       Impact factor: 6.725

10.  A structural basis for the pH-dependent xanthophyll cycle in Arabidopsis thaliana.

Authors:  Pascal Arnoux; Tomas Morosinotto; Giorgia Saga; Roberto Bassi; David Pignol
Journal:  Plant Cell       Date:  2009-07-28       Impact factor: 11.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.